OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest 
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany 
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 
DALLAS, May 03, 2018 -- via OTC PR WIRE--Puration, Inc. (USOTC:PURA) today released an image of the packaging design for THCSavor, the THC infused beverage the company has planned for production in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer.
|
|||||
“This packaging is a work in progress,” Said Brian Shibley, CEO of Puration. “Feel free to email us and tell us what you think. I’m enthusiastic about our new partners in Canada and look forward to sharing more details with you after we close the Canadian acquisition.”
Puration has scheduled a shareholder presentation for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/e769673c-f1aa-43fe-83dd-011a22393299
